Author

A Pereira

Institution: Hospital de Clínicas de Porto Alegre

Observed institution: Hospital de Clínicas de Porto Alegre

OpenAlex ID: A5159633841

Design and baseline data of AZURE-LDL, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with, or at risk for, ASCVD

2026 · E S Stroes, M Koren, et al. · European Heart Journal

Works count: 1

Citation count:

H-index:

I10-index: